-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QvEUc4lcXXjrUCHKFQxLQFCbvzGTpjPy+OzjfpfRKuwx7t79wTO8Fo+cON3qDQ/1 rUlRtwVAqo+EVppNn8yyRA== 0000950005-98-000100.txt : 19980212 0000950005-98-000100.hdr.sgml : 19980212 ACCESSION NUMBER: 0000950005-98-000100 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980211 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CELLEGY PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000887247 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820429727 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-45279 FILM NUMBER: 98530388 BUSINESS ADDRESS: STREET 1: 1065 E HILLSDALE BLVD STREET 2: SUITE 418 CITY: FORSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 4153826770 MAIL ADDRESS: STREET 1: 1065 E HILLSDALE BLVD STREET 2: SUITE 418 CITY: FORSTER CITY STATE: CA ZIP: 94404 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: TAVOLACCI DON C CENTRAL INDEX KEY: 0001007879 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 3542 MEADOWBROOK DR CITY: NAPA STATE: CA ZIP: 94558 BUSINESS PHONE: 7079960828 MAIL ADDRESS: STREET 1: 3542 MEADOWBROOK DRIVE CITY: NAPA STATE: CA ZIP: 94558 SC 13G/A 1 SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Cellegy Pharmaceuticals, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 15115L-10-3 --------------------------------------- (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 5 SCHEDULE 13G
- ----------------------------------------------- --------------------------------------------- CUSIP No. 15115L-10-3 Page 2 of 5 Pages ------------------------ ----------- ----------- - ----------------------------------------------- --------------------------------------------- - --------- -------------------------------------------------------------------------------------------------------- NAMES OF REPORTING PERSONS 1 S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS Don C. Tavolacci - --------- -------------------------------------------------------------------------------------------------------- CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 2 (a) |_| (b) |X| - --------- -------------------------------------------------------------------------------------------------------- 3 SEC USE ONLY - --------- -------------------------------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A. - --------------------------- ------- ------------------------------------------------------------------------------ 5 SOLE VOTING POWER NUMBER 217,033 OF ------- ------------------------------------------------------------------------------ SHARES 6 SHARED VOTING POWER BENEFICIALLY -0- OWNED ------- ------------------------------------------------------------------------------ BY 7 SOLE DISPOSITIVE POWER EACH 217,033 REPORTING ------- ------------------------------------------------------------------------------ PERSON 8 SHARED DISPOSITIVE POWER WITH -0- - --------------------------- ------- ------------------------------------------------------------------------------ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 217,033 - --------- -------------------------------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |_| - --------- -------------------------------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 2.14% - --------- -------------------------------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON IN - --------- --------------------------------------------------------------------------------------------------------
Page 2 of 5 Item 1. (a) Name of Issuer: Cellegy Pharmaceuticals, Inc. (b) Address of Issuer's Principal Executive Offices: 1065 East Hillsdale Blvd., Suite 418, Foster City, CA 94404 Item 2. (a) Name of Person Filing: Don C. Tavolacci (b) Address of Principal Business Office: 1065 East Hillsdale Blvd., Suite 418, Foster City, CA 94404 (c) Citizenship: U.S.A. (d) Title of Class of Securities: Common Stock (e) CUSIP Number: 15115L-10-3 Item 3. Not applicable. Item 4. Ownership (a) Amount Beneficially Owned: 217,033 (b) Percent of Class: 2.14% (c) Number of shares as to which such person has: (i) sole power to vote or direct the vote: 217,033 (ii) shared power to vote or direct the vote: -0- (iii) sole power to dispose or to direct the disposition of: 217,033 (iv) shared power to dispose or to direct the disposition of: -0- Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [x]. Item 6. Ownership of More Than Five Percent on Behalf of Another Person Not applicable Page 3 of 5 Item 7. Identification and Classification of Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company Not applicable. Item 8. Identification and Classification Members of the Group Not applicable. Item 9. Notice of Dissolution of Group Not applicable. Item 10. Certification By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect. Page 4 of 5 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. 2/11/98 - -------------------------------- Date /s/ Don C. Tavolacci - -------------------------------- Signature Don C. Tavolacci - -------------------------------- Name/Title Page 5 of 5 -----END PRIVACY-ENHANCED MESSAGE-----